Alemtuzumab (Campath) to Treat T-Large Granular Lymphocyte Leukemia

计划入组 29 人 · 首次发布于 2006 年 6 月 28 日

ABC008 in Subjects with T-cell Large Granular Lymphocytic Leukemia (T-LGLL)

计划入组 21 人 · 首次发布于 2022 年 9 月 8 日

Ruxolitinib for the Treatment of T-Cell Large Granular Lymphocytic Leukemia

计划入组 30 人 · 首次发布于 2022 年 10 月 24 日

JD002

ALECSAT

CELL AND GENE THERAPY CATAPULT

United Kingdom

Gamida Cell

Israel

GAMIDA CELL INC.

United States

Dizal Reports Promising Hematology Data at ASH 2025 with JAK1 Inhibitor Golidocitinib and Dual BTK/LYN Inhibitor Birelentinib

Tetraspecific NK Cell Engager IPH6501 Shows Promise in B-NHL Treatment

Emercell Receives EMA Approval to Study Allogeneic NK Cell Therapy for Diffuse Large B-Cell Lymphoma